Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5429]

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

Dr Ricky Frazer and Dr Sree Subramanian

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective ( Dr Ricky Frazer and Dr Sree Subramanian )

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid...

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair...

Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York...

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours ( Dr Yelena Yuriy Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal...

Dr Aditya Shreenivas - CIty of Hope, Duarte, USA

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal cancer shows positive results ( Dr Aditya Shreenivas - CIty of Hope, Duarte, USA )

Addition of pembrolizumab to standard care shows promising results in advanced...

Dr Ravindra Uppaluri - Dana-Farber Brigham Cancer Center, Boston, USA

Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer ( Dr Ravindra Uppaluri - Dana-Farber Brigham Cancer Center, Boston, USA )

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma

Dr Milad Ibrahim - NYU Langone Health, New York, USA

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma ( Dr Milad Ibrahim - NYU Langone Health, New York, USA )

Intraoperative radiotherapy: The Medical City experience

Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines

Intraoperative radiotherapy: The Medical City experience ( Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines )

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna...

ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in...

Dr Giulia Pasello - University of Padova, Padua, Italy

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC ( Dr Giulia Pasello - University of Padova, Padua, Italy )

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA...

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )

Taletrectinib superior to crizotinib in ROS1-positive non-small cell lung cancer

Dr Misako Nagasaka - UCI School of Medicine, Irvine, USA

Taletrectinib superior to crizotinib in ROS1-positive non-small cell lung cancer ( Dr Misako Nagasaka - UCI School of Medicine, Irvine, USA )

More from ecancer